Solas BioVentures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Phenomics Health builds a medication-response intelligence platform that combines high-complexity clinical laboratory testing, pharmacogenomics, pharmacometabolomics, and AI-enabled analytics to support precision prescribing and medication decisions.
AI & Machine LearningDigital HealthHealthtechPlymouth, US
Brian D. Athey(Co-founder)Daniel Jasewicz(Company Leadership (Strategy & Commercialization))inGerry Higgins(Scientific Strategy Lead)inAlex Ade(Technology & Data Science Lead)inPamela Weir(Director)Lew Wallace(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.